Published in Dement Geriatr Cogn Disord on November 28, 2007
Functional connectivity tracks clinical deterioration in Alzheimer's disease. Neurobiol Aging (2011) 2.01
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition. Brain (2011) 1.41
Alzheimer's disease: a clinical practice-oriented review. Front Neurol (2012) 0.95
The effect of education on rCBF changes in Alzheimer's disease: a longitudinal SPECT study. Eur J Nucl Med Mol Imaging (2008) 0.89
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease. BMC Neurol (2014) 0.82
Factors that influence survival in a probable Alzheimer disease cohort. Alzheimers Res Ther (2012) 0.81
Predictors of the progression of dementia severity in brazilian patients with Alzheimer's disease and vascular dementia. Int J Alzheimers Dis (2010) 0.78
The impact of brain size on pilot performance varies with aviation training and years of education. J Int Neuropsychol Soc (2010) 0.78
Education and Genetic Risk Modulate Hippocampal Structure in Alzheimer's Disease. Aging Dis (2016) 0.76
Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities. Curr Psychiatry Rep (2016) 0.75
Factors determining disease duration in Alzheimer's disease: a postmortem study of 103 cases using the Kaplan-Meier estimator and Cox regression. Biomed Res Int (2014) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation (1994) 12.24
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology (1999) 3.49
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty. Circulation (2001) 2.26
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 2.06
Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis (2011) 2.05
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04
Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet (1999) 1.95
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry (2012) 1.84
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.81
Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology (2006) 1.77
Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr (1998) 1.74
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology (1998) 1.68
Association of occurrence of aneurysmal bleeding with meteorologic variations in the north of France. Stroke (1994) 1.65
Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology (2007) 1.64
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet (2001) 1.62
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J (2002) 1.58
Prediction of pathology in primary progressive language and speech disorders. Neurology (2009) 1.57
Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology (2011) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. J Urol (2008) 1.56
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord (2001) 1.53
Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet (1998) 1.53
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation (2004) 1.52
Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50
Sex differences in awareness and control of hypertension in France. J Hypertens (1997) 1.49
Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J (2000) 1.45
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb (1992) 1.45
[Synthesis of delta-aminolevulinic acid and chlorophyll during illumination of etiolated Euglena gracilis]. Biochim Biophys Acta (1973) 1.44
Decreased morbidity from acute bacterial spinal epidural abscesses using computed tomography and nonsurgical treatment in selected patients. Ann Neurol (1985) 1.43
[Primary upper urinary tract tumors and subsequent location in the bladder]. Prog Urol (2009) 1.42
Need for caesarean sections in west Africa. Lancet (2002) 1.42
Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology (2001) 1.40
Emergence and scattering of multiple neurofibromatosis (NF1)-related sequences during hominoid evolution suggest a process of pericentromeric interchromosomal transposition. Hum Mol Genet (1997) 1.40
[Asynchronous implantation of a penile prosthesis (AMS 700) in patients with an artificial urinary sphincter (AMS 800): what functional outcomes can we expect from the AMS 1500?]. Prog Urol (2012) 1.40
[Erectile dysfunction after radical prostatectomy: pathophysiology, evaluation and treatment]. Prog Urol (2009) 1.39
[Analysis of the bibliometrics score of surgical department from the academic hospitals of Paris: what is the rank of urology?]. Prog Urol (2011) 1.39
Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol (1998) 1.37
Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol (1997) 1.36
Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin Cancer Res (1997) 1.32
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet (1997) 1.27
Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord (2000) 1.25
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS (2000) 1.23
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology (2002) 1.22
Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol (2004) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.20
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol (2012) 1.19
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet (2000) 1.18
Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol (1998) 1.17
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol (2001) 1.17
A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet (1998) 1.17
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience. Radiology (1998) 1.17
Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.16
The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet (2000) 1.16
CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol (1997) 1.15
A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.14